GLP-1 and dual GIP/GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound and others) are contraindicated — meaning you should not take them — if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), or a prior serious allergic reaction to the drug. They are also not recommended in pregnancy and are not for type 1 diabetes. If you have a history of pancreatitis, serious gut disease, gallbladder disease, or diabetic eye disease, the drug may still be an option — but only after a careful discussion with your clinician.
Key takeaways
- GLP-1s carry a boxed warning about thyroid C-cell tumors and are contraindicated with a personal or family history of MTC or MEN2.
- They are also contraindicated after a serious hypersensitivity reaction to the medicine.
- They are not recommended in pregnancy or when trying to conceive, and are not for type 1 diabetes.
- Pancreatitis, severe GI or gallbladder disease, and diabetic retinopathy call for caution and a clinician's judgment, not an automatic "no."
- Only a licensed clinician can decide whether a GLP-1 is safe for you — this article is general education.
Who should NOT take a GLP-1
Some situations are firm contraindications on the FDA prescribing information for these drugs. If any of these apply, a GLP-1 or dual GIP/GLP-1 agonist is generally not an option:
- A personal or family history of medullary thyroid carcinoma (MTC). This is a specific, uncommon type of thyroid cancer.
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2). This inherited syndrome raises the risk of MTC and other endocrine tumors.
- A prior serious allergic (hypersensitivity) reaction to the specific medication or any of its ingredients.
Two more groups are important. GLP-1 medications are not recommended during pregnancy or when actively trying to conceive, and they are not indicated for type 1 diabetes — they are not a substitute for insulin. If you are unsure which category you fall into, that uncertainty itself is a reason to talk to a clinician before starting.
Contraindications and cautions at a glance
It helps to separate the firm "no" list from the "proceed carefully" list. The table below summarizes the main categories from the prescribing information. It is a starting point for a conversation, not a self-screening tool.
| Condition or situation | Status | Why it matters |
|---|---|---|
| Personal/family history of MTC or MEN2 | Contraindicated | Boxed warning about thyroid C-cell tumors |
| Prior serious allergic reaction to the drug | Contraindicated | Risk of a repeat, potentially severe reaction |
| Pregnancy / trying to conceive | Not recommended | Not established as safe in pregnancy |
| Type 1 diabetes | Not indicated | Not a substitute for insulin |
| History of pancreatitis | Use with caution | Pancreatitis has been reported with these drugs |
| Severe GI disease / gastroparesis | Use with caution | Drugs slow gastric emptying and can worsen symptoms |
| Gallbladder disease | Use with caution | Gallbladder problems can occur, especially with rapid weight loss |
| Diabetic retinopathy (semaglutide) | Use with caution | Rapid glucose improvement has been linked to retinopathy changes |
Conditions that call for extra caution
Beyond the outright contraindications, several conditions don't rule a GLP-1 out but do change the risk calculation. Your clinician weighs these against the potential benefit for you.
A history of pancreatitis. Inflammation of the pancreas has been reported in people taking GLP-1 medications. If you have had pancreatitis before, your clinician will weigh that carefully and watch for warning signs.
Severe gastrointestinal disease or gastroparesis. Because these drugs deliberately slow how quickly the stomach empties, they can aggravate conditions that already involve delayed emptying or serious gut disease. Our overview of GLP-1 side effects covers the digestive effects in more detail.
Gallbladder disease. Gallstones and gallbladder problems can occur with these medicines, and the risk may rise with rapid weight loss. A history of gallbladder trouble is worth flagging.
Diabetic retinopathy. For semaglutide specifically, rapid improvement in blood sugar has been associated with worsening of diabetic eye disease in some people. If you have retinopathy, your clinician may monitor your eyes more closely.
When to stop and call your doctor
Even when a GLP-1 is appropriate for you, certain symptoms mean you should seek care promptly rather than wait. Treat these as red flags:
- Severe abdominal pain, especially pain that bores through to your back and comes with nausea or vomiting — a possible sign of pancreatitis.
- Persistent vomiting with signs of dehydration — dizziness, very little urine, a racing heart.
- Signs of a serious allergic reaction — swelling of the face, lips or throat, trouble breathing, or a severe rash.
These situations are uncommon, but they matter. Do not stop or change a prescription dose on your own; contact your clinician, and if symptoms are severe, seek urgent care. GLP-1s are also being studied and used for a growing list of conditions beyond diabetes and weight — our page on other uses of GLP-1s puts that in context — but the same safety rules apply across the board.
Frequently asked questions
Who should not take a GLP-1?
GLP-1 and dual GIP/GLP-1 medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and in anyone who has had a serious allergic reaction to the drug or its ingredients. They are also not recommended in pregnancy and are not used for type 1 diabetes. People with a history of pancreatitis, severe gastrointestinal disease, gallbladder disease, or diabetic retinopathy should discuss the risks carefully with a clinician.
Can you take a GLP-1 if you have thyroid problems?
It depends on the condition. GLP-1s carry a boxed warning about thyroid C-cell tumors based on rodent studies, and they are contraindicated if you or a close relative has had medullary thyroid carcinoma (MTC) or MEN2. Common thyroid conditions such as hypothyroidism are different and are not automatically a reason to avoid these drugs — but any thyroid history is something your clinician must know before prescribing.
Can you take a GLP-1 while pregnant?
GLP-1 medications are not recommended during pregnancy or when trying to conceive, and manufacturers generally advise stopping them before a planned pregnancy. If you become pregnant or are planning to, tell your clinician so they can review your treatment. This article is general education — your clinician makes the individual decision.
Can people with type 1 diabetes take a GLP-1?
GLP-1 receptor agonists are approved for type 2 diabetes and, for some products, weight management — not for type 1 diabetes. They are not a substitute for insulin. Anyone with type 1 diabetes should not use a GLP-1 for glucose control unless a specialist specifically directs it.
When should I stop a GLP-1 and call my doctor?
Seek prompt medical care for severe abdominal pain that may radiate to your back (a possible sign of pancreatitis), persistent vomiting with signs of dehydration, or signs of a serious allergic reaction such as swelling of the face or throat, trouble breathing, or a severe rash. Do not stop or change a prescription dose on your own without contacting your clinician.
Sources & further reading
- U.S. Food & Drug Administration — prescribing information, boxed warnings, and medication guides for semaglutide and tirzepatide products (Ozempic, Wegovy, Mounjaro, Zepbound).
- U.S. Food & Drug Administration — Contraindications and Warnings and Precautions sections of GLP-1 receptor agonist labels.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — incretin-based therapies overview.